1.215USD0.00%Mkt Cap: 129.08M USDP/E: —Last update: 2026-06-01
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrume…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap129.08M USD
Enterprise Value40.25M USD
Revenue (TTM)32.29M USD
Gross Profit26.80M USD
Net Income (TTM)-44.63M USD
Revenue/Share0.3030 USD
Last Price1.215 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees91
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.86
PEG—
EV/EBITDA-1.18
EV/Revenue1.25
P/S4.01
P/B0.77
EPS (TTM)-0.36
EPS (Forward)-0.25
52W Range
0.643033% of range2.400
52W High2.400 USD
52W Low0.6430 USD
Profitability
Gross Margin81.16%
Oper. Margin-64.09%
EBITDA Margin-105.80%
Profit Margin-135.14%
ROE-26.02%
ROA-22.04%
Growth
Revenue Growth-7.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-34.41M USD
CapEx (TTM)1.77M USD
FCF Margin-43.76%
FCF Yield-10.95%
Net Debt-89.37M USD
Net Debt/EBITDA2.62
Balance Sheet
Debt/Equity0.10
Current Ratio12.04
Quick Ratio10.88
Book Value/Sh1.567 USD
Cash/Share0.9980 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.107 USD
Target Range2.430 USD – 5.000 USD
# Analysts4
Ownership
Shares Out.107.12M
Float97.67M
Insiders1.37%
Institutions67.96%
Short Interest
Short Ratio5.0d
Short % Float4.46%
Short % Out.4.41%
Shares Short4.72M
Short (prev mo.)5.41M
Technical
SMA 500.8579 (+41.6%)
SMA 2001.228 (-1.0%)
Beta1.57
S&P 52W Chg27.94%
Avg Vol (30d)1.00M
Avg Vol (10d)1.26M
Technical Indicators
RSI (14)71.6
MACD0.0780
MACD Signal0.0604
MACD Hist.+0.0176
BB Upper1.231 USD
BB Middle0.9831 USD
BB Lower0.7352 USD
BB Width50.43%
ATR (14)0.0823 USD
Vol Ratio (20d)0.96x